Please assess the completion status of the following clinical trial:

Trial Title: PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>/= 18 years of age~* chronic hepatitis C~* informed consent to data collection~Exclusion Criteria:~* co-infection with HIV or Hepatitis B Virus (HBV)~* previous treatment with peginterferon and/or ribavirin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort (Type: None): Participants chronically infected with the hepatitis C virus including Genotypes 1 to 6.

Based on this trial design, predict the completion outcome and termination type (if applicable).